Spectranetics to Participate in Upcoming Investor Conferences
August 20, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Aug. 20, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in two upcoming investor...
Spectranetics to Present at the Canaccord Genuity 34th Annual Growth Conference
July 30, 2014 16:53 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 30, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be presenting at the Canaccord Genuity 34th Annual...
Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million
July 24, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 24, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today reported financial results for the three and six months ended June 30, 2014. Highlights of...
Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis
July 23, 2014 16:27 ET
|
The Spectranetics Corporation
Turbo-Tandem® and Turbo Elite® are indicated to treat peripheral ISR,
the only on-label products in the industry
EXCITE clinical trial proves safety, efficacy of laser technology;...
AngioScore Launches New 200 mm Length AngioSculpt(R) Scoring Balloon Catheters
July 09, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 9, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its wholly-owned subsidiary, AngioScore, Inc., developer of novel angioplasty...
Spectranetics to Hold 2014 Second Quarter Financial Results Conference Call on July 24
July 07, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2014 second quarter financial results after market...
Spectranetics Completes Acquisition of AngioScore Inc.
June 30, 2014 16:01 ET
|
The Spectranetics Corporation
Acquisition Expands Available Market Opportunity
Differentiated, Complementary Product Lines Combine to Provide Multiple Solutions for the Most Complex Cardiovascular Challenges
COLORADO...
EXCITE Clinical Trial Data Reported at NCVH Demonstrates Acute, Superior Procedural Success
June 04, 2014 12:58 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., June 4, 2014 (GLOBE NEWSWIRE) -- A presentation by principal investigator Eric J. Dippel, MD, of Genesis Heart Institute in Davenport, Iowa, at the annual New Cardiovascular...
Spectranetics Announces Closing of $230 Million Convertible Senior Notes Offering
June 03, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., June 3, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC), a developer and manufacturer of single-use medical devices used in minimally invasive procedures...
Spectranetics Announces Pricing of $200 Million Convertible Senior Notes Offering
May 29, 2014 08:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., May 29, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC), a developer and manufacturer of single-use medical devices used in minimally invasive procedures...